Monday, November 16, 2026

AMR: Global experts worry over rising antibiotic use, seek urgent action to avert superbug crisis


By Sola Charles 

With antibiotic use in livestock projected to rise by nearly 30 per cent by 2040, global health experts have warned that antimicrobial resistance (AMR) could become an even greater threat to human survival, food security and the environment unless governments move beyond policy commitments to urgent, coordinated action.

The experts warned that the growing misuse and overuse of antimicrobials, coupled with poor infection prevention, environmental pollution, weak surveillance and inadequate regulation, are accelerating the emergence and spread of drug-resistant infections that could undermine decades of medical and agricultural progress.

They called for governments to strengthen national AMR action plans, invest in surveillance and laboratory systems, regulate antimicrobial use in humans, animals and agriculture, and tackle pollution from pharmaceutical manufacturing, healthcare facilities and municipal wastewater systems.

The warning comes ahead of the 2026 World AMR Awareness Week (WAAW) November 18 to 24, with the theme, “One Health, One Action: Prevent AMR Now.”

Director (a.i.) of the Antimicrobial Resistance Department of the World Health Organisation (WHO) and Director of the Quadripartite Joint Secretariat on AMR, Dr Jean-Pierre Nyemazi, said: “AMR is one of the most urgent global health threats and development challenges. It threatens our ability to treat infections, protect animal and plant health, and produce safe food, and also has an impact on the environment.

“In 2021, bacterial AMR alone was associated with more than 4.7 million deaths, these are not just statistics, behind these numbers are patients, families, farmers and communities.

“AMR does not recognize borders or sectors. It is driven by the misuse and overuse of antimicrobials. It is also driven by gaps in infection prevention and control, poor water and sanitation, and contamination in the environment. Action in one sector affects all others,” Nyemazi said.

He said world leaders had already made commitments at the 2024 United Nations General Assembly High-Level Meeting on AMR, including a target to reduce deaths associated with bacterial AMR by 10 per cent by 2030, against the 2019 baseline of 4.95 million deaths.

Countries also committed to ensuring that at least 60 per cent had funded national action plans on AMR, alongside mobilisation of at least $100 million in catalytic funding to support implementation.

“However, let’s be honest. The gap between commitments and pledges versus implementation remains wide. Many countries face limited financing, fragmented coordination across sectors, and also weak surveillance and data systems, in addition to poor access or inappropriate use of antimicrobials across all the sectors,” he said.

Nyemazi disclosed that an updated Global Action Plan on AMR, covering 2026 to 2036, had been finalised to guide the next decade of interventions.

He also announced that the Fifth Global High-Level Ministerial Conference on AMR would hold in Abuja, Nigeria, from December 6 to 8, 2026, under the theme, “One Health: Advancing Global AMR Commitments through Local Action.”

The conference is expected to review global progress, address implementation gaps and renew political commitment, while the proposed Independent Panel on Evidence for Action against AMR is also expected to be launched.


Livestock antibiotics could rise 30%

Reinforcing the warning, Deputy Chief Veterinarian and Chief of the One Health and Disease Control Branch at the Food and Agriculture Organisation of the United Nations (FAO), Dr Junxia Song, said the agri-food sector must become a central part of the global response, warning that rising antibiotic consumption in livestock could worsen the resistance crisis.

"The urgency is clear. FAO’s recent study, ‘The Future of Antibiotics Use in Livestock,’ shows that without action, global antibiotic use in livestock could increase by nearly 30 percent by 2040. But with good practices on better animal health and better practices on farm management, antibiotic use could be reduced up to 57 percent. This is the power of prevention.

“We must reduce the need for antibiotics while ensuring effective antimicrobials remain available and are used responsibly when treatment is necessary,” she said.

Song said FAO's 2026 to 2036 AMR roadmap would translate global commitments into practical interventions across the agri-food system, with emphasis on stronger national action plans, prevention, surveillance, laboratory capacity and sustainable financing.

She, however, identified inadequate integration of agricultural priorities into national AMR plans as a major weakness, noting that nearly half of countries had either no legislation or only partial legislation governing antimicrobial use in animal and plant health.

According to her, farmers must be placed at the centre of the response through FAO's 10-year initiative, Reduce the Need for Antimicrobials on Farms (RENOFARM).

The initiative is built around five interconnected areas: good health services, good production practices, good alternatives and innovation, good incentives and good connections, collectively described as the 5G farm approach.

More than 400 partners, including over 80 FAO Member Countries, individual experts and international and regional organisations, were already engaged in the initiative.

“Better data can help countries understand their national situation, strengthen policies and regulations, and direct limited resources where they can have the greatest impact.

“Awareness and commitments are important, but they are not enough. Countries and farmers need stronger services, incentives, financing and capacity. So, our solutions must be practical, affordable and rewarding for farmers,” she noted.

Pollution is fuelling resistance

Adding an environmental dimension to the warning, AMR Coordinator, Chemicals and Health Branch, United Nations Environment Programme (UNEP), Aitziber Echeverria, cautioned that efforts to tackle drug resistance would remain incomplete if governments continued to treat it exclusively as a human health and agricultural problem.

She said the environment plays a significant role in the emergence, transmission and spread of antimicrobial resistance, with antimicrobial residues, resistant microorganisms and resistance genes entering ecosystems through pollution.

“AMR is often discussed as a public health and agriculture challenge — which of course it is, and a major one — but it is an environmental issue too,” she said.

Referring to UNEP's report, Bracing for Superbugs: Strengthening Environmental Action in the One Health Response, Echeverria said the environmental dimension of AMR must be addressed as an integral part of the global response.

According to her, pharmaceutical manufacturing must reduce the discharge of antimicrobial residues, while more sustainable agricultural practices can limit pollution from animal and crop production.

Healthcare facilities also need stronger antimicrobial stewardship, while municipal authorities must address untreated or inadequately treated waste and wastewater that can create conditions for resistance to emerge and spread.

She said preventing pollution at its source was critical, warning that environmental contamination could undermine gains made through interventions in human and animal health.

“All this brings us to stress that the most urgent action is prevention. We need to reduce the release of antimicrobial residues, resistant microorganisms and genes into the environment before they become a challenge. This means tackling pollution at its source — upstream,” she said.

Echeverria described the December 2025 adoption of a United Nations Environment Assembly resolution on the environmental dimensions of AMR as a significant milestone, but stressed that countries must now translate policy recognition into funded interventions.

She called for stronger environmental monitoring and surveillance systems, explaining that environmental data could help identify AMR hotspots and sources of contamination before they become more serious threats.

She also urged governments to formally include environmental authorities and institutions in national AMR governance structures rather than treating them as peripheral stakeholders.

“Too often they do not play an active role and environmental expertise is brought in only later,” she said.

According to her, environmental objectives and indicators must be incorporated into national AMR action plans and backed by adequate financing.

Making a strong case for integrated action, Echeverria warned that environmental interventions were not optional additions to the global response.

“Environmental action on AMR is not an optional addition to the response. It is a prerequisite for success in addressing AMR with One Health approach. If we do not address the environmental dimensions of AMR, we risk undermining efforts in human and animal health.”

She added that tackling environmental drivers of AMR would also deliver wider benefits, including improved public health, biodiversity protection, water security and progress against climate change, nature loss and pollution.

Her position was that countries must stop treating human health, animal health, agriculture and the environment as separate policy concerns.




### AMR: WHO, WOAH warn of widening implementation gaps, call for urgent investment in prevention

By Sola Ogundipe

The fight against antimicrobial resistance (AMR) risks losing ground unless countries move beyond political commitments to adequately fund prevention, strengthen surveillance, expand laboratory capacity and ensure responsible use of medicines across human, animal and environmental health, experts have warned.

They said the growing threat of drug-resistant infections requires urgent action across sectors, warning that weak health systems, inadequate financing, poor disease prevention and inappropriate antimicrobial use are undermining efforts to contain a crisis that threatens lives, food security and livelihoods.

With the updated Global Action Plan on Antimicrobial Resistance 2026–2036 setting a new framework for the next decade, experts say the challenge is now to translate international commitments into measurable results at country level.

The warning comes ahead of the Fifth Global High-Level Ministerial Conference on AMR in Abuja next month, where governments and international partners are expected to renew commitments to tackling antimicrobial resistance.

Speaking on the implementation challenges, Dr Kefas Samson, Senior Technical Officer and Lead of Multisectoral Coordination, AMR Department, World Health Organisation (WHO) headquarters, said although political commitment had strengthened considerably, countries were still struggling with the resources and systems needed to deliver results.

Samson said the WHO, through the Quadripartite Joint Secretariat on AMR, was working with the Food and Agriculture Organisation (FAO), United Nations Environment Programme (UNEP) and World Organisation for Animal Health (WOAH) to help countries translate global commitments into practical interventions.

He said: “In terms of priorities and implementation gaps for WHO: evidently, to ensure that countries can effectively translate these global commitments into action, the focus of WHO is also on ensuring that these countries are able to assess their needs, prioritize and cost their interventions, and tailor implementations to their local realities and available resources as well.”

He identified inadequate financing, weak nationwide surveillance, poor diagnostic capacity and limited access to quality-assured antimicrobials as major obstacles slowing progress.

“Significant gaps still persist, and progress among countries also remains uneven. Notable among those challenges include inadequate financing to actually support the desired level of acceleration of implementation; gaps in nationwide implementation of AMR and antimicrobial use surveillance; as well as in the institution of preventive measures, particularly in healthcare facilities.

“There is also the issue of inadequate diagnostic capacity to support treatment decisions, as well as gaps in access to quality-assured antimicrobials, which is really a key issue. These gaps are also compounded by shortage of healthcare workforce, just like in other sectors, and inequitable access to the products that are required to support clinical activities.”

Beyond hospitals and specialist health facilities, Samson said primary healthcare and community-based services must become central to the AMR response, particularly in preventing infections, promoting behavioural change, improving early diagnosis and ensuring appropriate treatment.

He explained that the updated Global Action Plan 2026–2036 was designed to move countries from broad commitments to measurable implementation, with stronger emphasis on One Health collaboration, prevention, surveillance, research, innovation and sustainable financing.

“The Global Action Plan on AMR 2026-2036 provides a renewed blueprint for accelerating the implementation of actions to address the AMR issue but also being more measurable in terms of how impact and outcomes are intended to be measured. It is not just a plan now; but a framework that translates the aspirations and ambitions of the political declaration on AMR 2024 into tangible actions at the country level.”

According to him, the plan also seeks to strengthen laboratory capacity, improve access to essential antimicrobials and promote responsible use, while addressing weaknesses in supply chains and governance.

He said WHO was working towards the 2030 targets, including ensuring that 70 per cent of antibiotics used in the human health sector belong to the WHO Access group and that 80 per cent of countries can test for priority bacterial and fungal pathogens under the WHO Global Antimicrobial Resistance and Use Surveillance System.

Another major target, he said, was the commitment by Member States to reduce deaths associated with bacterial AMR by 10 per cent by 2030, compared with the 2019 baseline.

Samson stressed that countries must also be supported to secure catalytic funding and strengthen implementation of their multisectoral national action plans.

The animal health dimension of the crisis, according to WOAH, is equally critical, with preventable infections in livestock and other animals contributing to antimicrobial use and the wider resistance problem.

Dr Jane Lwoyero, Programme Officer, WOAH, said prevention, vaccination, surveillance, cross-sectoral coordination and sustainable financing were central to the organisation's strategy for reducing antimicrobial use in animals.

She disclosed that animal diseases account for losses estimated at up to $300 billion annually, much of which could be reduced through preventive measures, including vaccination, farm biosecurity, early detection and rapid response.

Despite the importance of vaccination, Lwoyero said fewer than 20 per cent of WOAH Member Countries vaccinate animals against notifiable diseases.

She said WOAH had established an ad hoc animal health group, PROEVA, to identify priority animal diseases for which vaccines could reduce the need for antibiotics in pigs, poultry and fish.

The organisation had also established the PREVENT Forum, a public-private platform designed to address barriers to vaccination, including regulatory challenges, affordability, access, equity and the development of national vaccination strategies.

On antimicrobial consumption, Lwoyero disclosed that previous WOAH ANIMUSE reports showed a three per cent reduction in global antimicrobial use in animals between 2019 and 2024.

However, she warned that the continued use of antibiotics for growth promotion remained a major concern.

According to her, countries that permit the practice tend to use 45 per cent more antimicrobials than those that do not.

“74% countries do not use antimicrobial growth promoters, 19% report using them, and 7% do not report but are still unknown regarding using antimicrobials for growth promotion,” she said.

Lwoyero said WOAH was encouraging countries to discontinue the practice, stressing that antibiotics should not be used to compensate for poor animal husbandry, inadequate farm hygiene or weak disease prevention.

She said: “We need also to commit to using antimicrobials in animals prudently and responsibly. This also goes hand-in-hand with vaccination strategies, farm biosecurity strengthening, good animal husbandry practices, because all these work together to reduce the need for antimicrobials — and when we need them, then let’s use them prudently and responsibly.”

She also called for greater investment in veterinary services, describing chronic underfunding of animal health systems as a major obstacle to containing AMR.

Citing WOAH findings, she said every dollar invested in preventing animal diseases and strengthening animal health systems could generate a return of $28.

“This will reduce the need for antimicrobials while protecting livelihoods and public health,” she said.

Lwoyero warned that the human health consequences of AMR could not be separated from what happens on farms, in food production systems and in the environment.

“When we protect human health, it does not only start when they are at the clinic. This protection starts with stronger animal health systems, because these assure us that the animals will be healthy, the food from these animals will be healthy, and therefore people interacting with the animals and with the food from the animals will also be healthy.”

She further called for increased contributions to the AMR Multi-Partner Trust Fund, which she said had been instrumental in helping countries scale up implementation of their national action plans.

Meanwhile, Chairperson of the Global AMR Media Alliance (GAMA), Shobha Shukla, said the threat of drug resistance was much closer to everyday life than many people realised.

She warned that seemingly minor injuries, including cuts and needle pricks, could expose people to drug-resistant infections that may be difficult or even impossible to treat.

“A simple injury – a cut or a needle prick or any other such day-to-day accident - can put us at risk of getting infected with drug-resistant infections – which could be difficult to treat due to AMR or worse – incurable.

“This could happen to our lovely plants and animals too – and is polluting our environment – our mother Earth too. We need to save the medicines that protect us. We are talking about antibiotics, antifungals, antivirals and antiparasitics or other medicines. We need to stop misuse and overuse of medicines that fuels antimicrobial resistance. And most importantly, we need to ensure no one gets infected with preventable infectious diseases.”

Shukla said the 2026 World AMR Awareness Week, observed globally from November 18 to 24, was themed: “One Health, one action: Prevent AMR now.”

She noted that AMR remained among the world's top 10 global health threats and posed a serious danger to food security, adding that the priority must shift from simply encouraging countries to develop national action plans to ensuring they have the capacity to implement them.

“The central challenge is no longer simply getting countries to recognise AMR or develop national action plans. It is ensuring that countries have the funding, surveillance systems, laboratory capacity, effective interventions and accountability mechanisms to implement them.”

According to her, the updated Global Action Plan offers an opportunity to strengthen prevention-first interventions, promote sustainable agrifood systems, address environmental drivers of resistance and improve national accountability.

However, she cautioned that efforts to curb inappropriate antimicrobial use must not deprive patients who genuinely need these medicines of access to effective treatment.

“Countries responses must balance preventing unnecessary antimicrobial use while ensuring people who genuinely need effective medicines can obtain them. A multi-sectoral response under the One Health banner is warranted to prevent AMR. Equally important is to humanize AMR response at all levels in a person-centred, rights-based and gender transformative manner.”

The experts agreed that the success of the new global action plan would ultimately depend on whether governments backed their commitments with sustained financing, functional surveillance systems, accessible diagnostics and coordinated action across human, animal, agricultural and environmental health.

For countries such as Nigeria, hosting the Fifth Global High-Level Ministerial Conference on AMR presents an opportunity to move the conversation beyond declarations and establish concrete national priorities, financing commitments and accountability mechanisms for implementation.

The message from the experts is clear: preventing infections, protecting the effectiveness of existing medicines and strengthening health systems must happen together. The cost of delaying action will extend far beyond hospitals, reaching farms, food systems, households and the wider environment.






The message from the experts is that antimicrobial resistance cannot be contained by hospitals, doctors or pharmaceutical regulation alone. It requires action across farms, food production systems, industries, communities and government institutions.

With the Abuja ministerial conference approaching, the challenge for governments is increasingly clear: translate global commitments into funded national programmes, enforce existing regulations and make prevention a priority before drug-resistant infections become even harder to treat.

Eritrea becomes 11th African country to eliminate trachoma


By Precious Dipe 

Eritrea has become the 11th country in the World Health Organization (WHO) African Region to eliminate trachoma as a public health problem, marking a major breakthrough in the fight against one of the world's leading infectious causes of blindness.

The WHO validation makes Eritrea the 34th country globally to achieve the milestone, following two decades of sustained interventions targeting the disease, particularly in remote rural communities where poor access to clean water, sanitation and healthcare had fuelled its spread.

Eritrea is also the 66th country globally and the 23rd in the WHO African Region to eliminate at least one neglected tropical disease.

Congratulating the country, WHO Director-General, Dr Tedros Adhanom Ghebreyesus, described the achievement as a victory for communities that had endured the devastating effects of the disease.

“I congratulate the Government and people of Eritrea on this historic achievement,” Tedros said.

“After two decades of determined effort, Eritrea has consigned trachoma as a public health problem to history. This is a victory for the communities most affected by this devastating disease, and a powerful example of what sustained national commitment can achieve.”

Eritrea's success followed nationwide surveys conducted between 2006 and 2020, which helped identify affected communities and guide the rollout of interventions across the country.

The government subsequently implemented WHO's recommended SAFE strategy, a combination of surgery for advanced cases, antibiotics to clear infection, facial cleanliness to limit transmission and environmental improvements, particularly better access to water and sanitation.

The programme covered all 58 sub-zobas, the country's second-level administrative areas, with interventions scaled up in communities where the disease remained endemic.

A notable feature of the campaign was its community-led sanitation approach, which delivered significant public health gains despite limited external funding.

Health workers also deployed digital tools for data collection and mapping to identify affected populations, track disease patterns and direct resources to hard-to-reach communities.

The antibiotic component relied largely on oral azithromycin donated by Pfizer Inc. through the International Trachoma Initiative.

WHO Regional Director for Africa, Dr Mohamed Janabi, said Eritrea's achievement demonstrated the impact of political commitment, community participation and effective partnerships in tackling neglected tropical diseases.

“I congratulate Eritrea on this historic public health milestone. It shows what is possible through sustained political commitment, community leadership and strong partnerships,” Janabi said.

He added that the achievement offered encouragement to other African countries still battling trachoma.

“Eritrea’s achievement brings us closer to a world free from the suffering caused by neglected tropical diseases and sends a strong message of hope to other African countries working towards trachoma elimination. With determination and collective action, we can protect the health and well-being of communities and leave no one behind.”

WHO Representative to Eritrea, Dr Mary Stephen, attributed the success to national ownership and collaboration among communities, the Ministry of Health, the Fred Hollows Foundation, development partners and frontline health workers.

"This success belongs first and foremost to the people of Eritrea. The elimination of trachoma as a public health problem is the result of strong national leadership and ownership, and collaboration between communities, the Ministry of Health, the Fred Hollows Foundation, development partners and health workers across the country,” she said.

Stephen said WHO would continue working with the government and its partners to sustain the gains and prevent a resurgence of the disease.

Although Eritrea has crossed the elimination threshold, the country has established systems to identify and manage new cases of trachomatous trichiasis, the advanced stage of the disease, and will continue surveillance to detect any recurrence.


Nigeria intensifies elimination push 

While Eritrea has secured WHO validation, Nigeria is making significant progress towards eliminating trachoma, although the disease remains a public health challenge in some parts of the country.

The Federal Ministry of Health and Social Welfare disclosed in July 2026 that 11 local government areas (LGAs) remained to achieve elimination status out of 134 previously identified endemic LGAs.

The country has stopped mass drug administration (MDA) in 116 LGAs after they met the WHO elimination threshold, representing approximately 87 per cent progress towards eliminating the disease in affected areas.

Director and Programme Manager of the National Trachoma Programme, Nicholas Olobio, said Nigeria had also performed more than 100,000 surgeries for trachomatous trichiasis, the advanced stage of the disease that can cause irreversible blindness.

Insecurity remains a major obstacle to completing the elimination drive. The Chairman of the National Trachoma Task Force, Adamu Mohammed, said seven of the 11 remaining endemic LGAs are in Borno State, where security challenges have restricted access to affected communities.

Nigeria's progress has been driven by the implementation of WHO's SAFE strategy, supported by mass antibiotic distribution, eye surgeries, hygiene promotion and improved access to water and sanitation.

A study published in the International Health journal in January 2025 documented that Nigeria had distributed more than 34 million antibiotic treatments in 104 LGAs by 2021, while 102,527 people had received treatment for trachomatous trichiasis.

The study, titled Progress towards the elimination of trachoma in Nigeria, concluded that eliminating the disease by 2030 was feasible, provided funding support was sustained. 

Trachoma is among the 21 diseases and disease groups covered by WHO's Neglected Tropical Diseases Roadmap 2021–2030, which seeks to accelerate prevention, control, elimination and eradication efforts, particularly among populations living in poverty and underserved communities.

Trachoma is caused by the bacterium Chlamydia trachomatis and spreads through contact with eye and nasal discharge from infected people. Repeated infections can cause scarring of the inner eyelid, forcing the eyelashes to turn inward and scratch the eyeball. Without treatment, the condition can cause irreversible blindness.

The disease disproportionately affects poor and underserved communities, particularly those with inadequate access to clean water, sanitation, hygiene facilities and essential healthcare. Despite significant global progress, the disease remains a public health challenge in parts of the world.

According to WHO, the global population requiring interventions against trachoma has fallen from an estimated 1.5 billion in 2002 to fewer than 100 million by November 2025, representing a reduction of about 94 per cent.

However, as of March 2026, approximately 92 million people still lived in trachoma-endemic areas and remained at risk of blindness. The disease continued to pose a public health problem in at least 29 countries. In 2025 alone, 98,829 people underwent surgery for advanced trachoma, while 47.4 million received antibiotics.

Sunday, November 15, 2026

RisQ Summit: Expert pushes unified emergency response system in Nigeria



By Sola Charles 


Nigeria needs a unified emergency response system that connects patients to ambulances, appropriately equipped hospitals, medical specialists and health insurance providers through a single call, an emergency care expert and healthcare entrepreneur has stated.

Giving the warning in Lagos,during the inaugural ResQ Summit 2026, Dr. Aisha Onisarotu Atanda, who is the Chief Executive Officer of The Ambulance Company, ResQCore and TAC Care, said that the absence of such coordination continues to expose patients to avoidable delays and risks.

Atanda, who convened the Summit themed "Building a Coordinated Emergency System", said an integrated emergency care network would eliminate the burden on patients and their relatives to independently arrange transportation, identify suitable hospitals, secure specialist intervention and negotiate access to treatment during life-threatening situations.

Speaking at the Rescue Summit 2026, themed “Building a Coordinated Emergency Care System”, Atanda said Nigeria already had organisations and resources providing different aspects of emergency care, but poor coordination prevented them from functioning as one effective system.

She said the current arrangement often left families struggling to determine which emergency number to call, secure an ambulance and identify a hospital capable of managing the patient's condition, resulting in delays that could compromise survival.

“The problem we have at the moment is that many organisations operate in silos. Hospitals operate independently. Ambulance companies and health maintenance organisations are also doing their own thing, all with the right intention of improving emergency care.

“However, when these organisations operate in silos, patients and their relatives are left to navigate the system themselves. They have to figure out which number to call, contact an ambulance and then decide where the patient should be taken,” Atanda said.

She noted that the proposed model would ensure that once an emergency call was received, the patient's location and condition would be established, an appropriate ambulance dispatched and a receiving hospital with the capacity to provide the required treatment identified.

Atanda said the initiative is particularly important in emergencies involving burns, complicated pregnancies and other conditions requiring specialised intervention, where taking a patient to the wrong facility could result in dangerous delays.

“The patient's relatives may not have the expertise to know, for instance, that a burn victim needs to be taken to a specialist burns centre. As a result, valuable time is wasted accessing the wrong care when the patient could have been connected to the right facility through a coordinated system,” she added.

Atanda, who co-founded an ambulance service provider and subsequently developed technology for coordinating emergency services, said her organisation had also extended its activities to intensive care and surgical services through TAC Care at the Lagos State University Teaching Hospital, LASUTH.

She said the objective was to demonstrate how an integrated emergency response model could work and encourage governments to adopt and strengthen similar arrangements.

On complaints about unanswered emergency calls and delayed ambulance response, Atanda said a properly coordinated system must guarantee round-the-clock communication and effective dispatch of emergency services.

“We operate a 24-hour communication centre where someone is available to receive calls, establish the caller's location and coordinate assistance. The goal is to ensure that patients receive the support they need throughout their emergency care journey,” she said.

She added that private sector initiatives could demonstrate workable models that government agencies could subsequently integrate into the national emergency response framework.

On the cost of emergency treatment, Atanda acknowledged that quality healthcare remained expensive but argued that health insurance offered one of the most sustainable ways of reducing the financial burden on patients and their families.

“We cannot continue to rely on out-of-pocket payments for every healthcare emergency. It is simply not sustainable,” she said.

Beyond insurance, Atanda called for stronger government-private sector partnerships, noting that the government had the authority to formulate policies and wider community reach, while private organisations could contribute operational expertise and service delivery capacity.

“There should be policies that make health insurance compulsory, while the government can also pool resources and allocate funds specifically for emergency care,

“The faster a patient accesses appropriate care, the better the chances of survival and recovery. If it takes days before someone receives treatment, the likelihood of a positive outcome becomes significantly lower,” she said.

The emergency care advocate also called for stronger public preparedness, saying Nigerians needed to understand how to recognise emergencies, seek assistance and provide basic first aid before professional responders arrived.

She said public education and first aid training were essential because emergency responders might not reach victims immediately after an incident.

“When you call for help, it may take at least five minutes for emergency responders to reach you. What do you do during those minutes before help arrives?” she asked.

She urged Nigerians to acquire basic skills to recognise conditions such as seizures and strokes, understand the appropriate response and provide accurate information when contacting emergency services.

Atanda said her ambulance company provided first aid training for individuals, corporate organisations and healthcare professionals, but stressed the need to expand such programmes and make emergency preparedness part of everyday life.

“We need to make emergency response information part of our everyday lives so that people understand how to seek help when emergencies occur,” she said.

She maintained that building a functional emergency care system would require sustained collaboration, public education, accessible health insurance and a reliable network capable of connecting patients to appropriate care without unnecessary delays

Bundibugyo virus: Nigeria records zero transmission as 62 contacts complete monitoring

...NCDC confirms recovery of index patient in Switzerland, 13 symptomatic contacts, 7 suspected cases test negative





By Sola Charles


Nigeria has recorded no secondary transmission of the deadly Bundibugyo virus disease, an Ebola-related illness, following the completion of a 21-day monitoring period for all 62 contacts linked to the country's imported case.

The Nigeria Centre for Disease Control and Prevention (NCDC) announced on Sunday that the last contact had been discharged from monitoring, bringing to an end a critical phase of the national response without a single confirmed infection among those exposed to the index patient.

The development comes as the country steps up preparations for increased human movement and public gatherings ahead of the December festive season, with health authorities warning that the absence of secondary transmission does not mean Nigeria can lower its guard against further importation of the disease.

Director-General of NCDC, Dr Jide Idris, who announced the development, said all 62 identified contacts had completed the mandatory monitoring period without developing Bundibugyo virus disease.

He disclosed that 13 contacts who reported fever and other nonspecific symptoms during the monitoring period were tested for the virus, with all returning negative results.

Similarly, seven suspected cases reported in Adamawa, Rivers, Borno, Lagos and Ekiti states within the past three weeks were investigated and confirmed negative.

The index case, an imported infection confirmed in the Federal Capital Territory on October 20, 2026, triggered the activation of Nigeria's national emergency response machinery and heightened surveillance across the country.

In a significant development, Idris also confirmed that the infected patient, who was medically evacuated to Switzerland on October 26 for further treatment, had recovered, subsequently tested negative for the virus and been discharged from hospital.

However, the NCDC chief cautioned against interpreting the successful completion of contact monitoring as a formal declaration that the outbreak was over.

He said such a declaration must be guided by established public health criteria and findings from continuing surveillance.

"Our responsibility does not end here," Idris said, stressing that Nigeria would sustain heightened surveillance, laboratory investigation of suspected cases and infection prevention measures despite the encouraging outcome.

According to him, the country's National Emergency Operations Centre remains activated, with the Incident Management System operating at Level 3, the highest response level for Ebola virus disease.

The response was triggered by an alert raised by healthcare workers through NCDC's event-based surveillance system, which enabled authorities to investigate the suspected infection and initiate containment measures.

Under the leadership of the Coordinating Minister of Health and Social Welfare, Professor Muhammad Ali Pate, the national emergency operations centre was activated, bringing together relevant institutions to coordinate case management, contact tracing, laboratory testing and risk communication.

The agency said contacts were traced across healthcare facilities, households and other relevant settings, while infection prevention and control measures were reinforced in health facilities, particularly in the FCT.

Healthcare workers received additional training, while personal protective equipment and other response supplies were provided to support activities at the affected facility and relevant points of entry.

The NCDC also intensified public communication to counter misinformation, which Idris warned could generate unnecessary fear, erode public confidence and discourage people from seeking medical attention.

But with the festive season approaching, the agency is particularly concerned about the public health implications of increased travel, religious gatherings, political activities, concerts, festivals and sporting events.

Idris urged Nigerians and international visitors to seek medical attention promptly if they become unwell, warning against the tendency to dismiss every fever as malaria, particularly among people with recent travel history or possible exposure to infectious diseases.

He advised travellers to disclose their travel history and any possible exposure to healthcare workers, stressing that such information could prove critical to early detection and appropriate management.

He also urged Nigerians to avoid unprotected contact with the blood and other body fluids of anyone suspected of having Ebola or any other infectious disease.

Organisers of mass gatherings, including religious institutions, political organisations and event promoters, were advised to provide adequate sanitation, safe drinking water and access to medical assistance, as well as establish arrangements for promptly reporting suspected illnesses.

The NCDC said it had developed public health guidance for mass gatherings to help organisers and participants minimise health risks.

Healthcare workers in both public and private facilities were also urged to maintain a high index of suspicion, observe appropriate infection prevention precautions and report suspected cases without delay.

All inbound international travellers are still required to complete the Nigeria Health Declaration Form before arrival, with the agency urging them to provide accurate information about their health and travel history.

The latest development comes against the backdrop of continued Ebola virus disease activity in the Democratic Republic of Congo, which the NCDC said reinforces the need for Nigeria to maintain preparedness against possible importation.

Idris said lessons from the response would inform improvements in disease surveillance, clinical readiness, infection prevention and control, and coordination between national and state health authorities.

He particularly commended the private hospital in the FCT where the index patient was initially treated, noting that its healthcare workers raised the alert that led to the detection of the infection.

He described their vigilance and continued care for the patient, in coordination with public health authorities, as evidence of the critical role private healthcare providers play in national disease surveillance and emergency response.

The NCDC also acknowledged the contributions of the FCT Health Services Secretariat, Port Health Services, government institutions and national and international partners.

While expressing appreciation to the 62 contacts and their families for complying with monitoring and quarantine requirements, Idris maintained that public cooperation remained central to preventing further transmission.

"There is no reason for panic. What is required is continued vigilance, early reporting and cooperation with public health authorities," he said.

Editorial note: The strongest angle is the combination of zero secondary transmission, the recovery of the index patient and the successful completion of monitoring by all 62 contacts. I have retained the distinction between completing contact monitoring and formally declaring an outbreak over, which is important for accuracy.

Friday, November 13, 2026

Nigeria poised to lead new era of health system transformation -- WHO



By Sola Ogundipe 


Reform of the global health architecture is now being driven by a Member State-led process established by the 79th World Health Assembly in May 2026. Hosted by the World Health Organisation (WHO), it brings together UN agencies, Gavi, the Global Fund, the Pandemic Fund, the World Bank and regional health organisations to develop a more coherent, country-led system with clearer mandates and financing aligned with national priorities. The reform options will go before participating institutions’ governing boards between late 2026 and February 2027, ahead of recommendations to the World Health Assembly in May 2027. The process is linked to the UN80 reform initiative and Africa’s Accra Reset, which promotes health sovereignty. In this interview, the WHO Representative and Head of Mission, Nigeria, Dr. Pavel Ursu, reflects on the Global Health Architecture Reform from the country level perspective. Excerpts:


What the reset means for health outcomes in Nigeria

The first point is that the reset is a Member State-driven process. As institutions and partners in global health, we respect that process and look forward to its outcomes and the decisions of Member States on how we should focus and adapt our work. The structural questions being considered are important, and the reshaping of the global health architecture should follow this process. However, if you ask what this should ultimately mean for Nigerians, my perspective is pragmatic. The reset itself will not change health outcomes in Nigeria, certainly not in the short term. What matters is whether the changes it produces help countries translate resources, partnerships and technical capacity into stronger services and better health outcomes. For a mother in Sokoto or a child in Borno, the global health architecture is quite distant. What matters is whether it strengthens the services people depend on: primary healthcare, functioning supply chains, surveillance and laboratory systems, and adequately equipped and supported health workers.
Countries do not have to wait for the global process to accelerate progress. When governments invest domestic resources through national plans, strengthen accountability and align partners behind national priorities, they build the foundations that any future global health architecture should support. Nigeria already has important foundations through the Health Sector Renewal Investment Initiative and the Sector-Wide Approach (SWAp). These offer opportunities to strengthen country ownership, partner alignment and accountability. The Joint Annual Review, alongside quarterly performance reviews, should go beyond assessing progress to identifying bottlenecks, correcting course and accelerating measurable results.
The Lusaka Agenda and Africa's Accra Reset reinforce this direction towards greater country leadership and stronger alignment of global health initiatives with national priorities. Nigeria has an opportunity not only to accelerate its own progress but also to demonstrate what country-led transformation can achieve. Ultimately, the test of the reset will be whether it enables countries such as Nigeria to lead more effectively, mobilise sustainable domestic financing, coordinate partners behind national priorities and translate these efforts into better health outcomes.

Role of country capacity in achieving impact

National capacity is the pillar on which the others rest. Sustainable progress depends on countries being able to plan, finance, deliver, measure and continuously improve health services. International support is most effective when aligned with national priorities, systems and accountability mechanisms. I would assess any proposal, whether it involves merging agencies, pooling funds or setting timelines for reducing external aid, against one question: will it leave Nigeria's health system more capable five years from now than it is today?

Where results should show: Polio and immunisation

Nigeria was certified free of wild poliovirus in 2020, a remarkable national achievement that many once considered impossible. However, variant poliovirus continues to circulate. According to the Global Polio Eradication Initiative's October 28, 2026 update, Nigeria had reported 36 type 2 variant cases this year, down from 66 in 2025, alongside 15 type 3 cases, up from eight. The August IHR Emergency Committee noted that Nigeria remains the largest contributor to the global variant poliovirus caseload.
The priority now is improving delivery and making better use of limited resources. Transmission is concentrated in a number of local government areas in the North-West, where campaign quality, access and routine immunisation remain weak. We are working with NPHCDA and state governments to address each of these LGAs as a specific delivery challenge, with clearly assigned responsibilities, weekly performance reviews and a focused set of indicators. Rather than applying uniform national measures, interventions must respond to local realities. A better-aligned global health architecture can help by providing predictable funding for targeted interventions, but Nigerian programme managers must lead implementation on the ground.

Where routine immunisation stands

This is where polio will ultimately be won or lost. WHO and UNICEF estimates put Nigeria's zero-dose children at approximately 2.2 million in 2025. National administrative data often show higher immunisation coverage than surveys and modelled estimates. That discrepancy highlights the need to improve data quality and population denominators. The surveillance systems, microplanning structures and community networks built around polio must increasingly support routine immunisation and primary healthcare. Making that transition is one of Nigeria's most important health system capacity challenges.

Making global funding instruments work for malaria, TB and HIV

External investments have saved millions of lives globally and remain important. However, their effectiveness must be measured against the disease burden. WHO's World Malaria Report 2025 estimates that Nigeria accounted for 24.3 per cent of global malaria cases and 30.3 per cent of deaths in 2024, representing approximately 68.5 million cases and 185,000 deaths. Nigeria therefore carries the largest share of the global malaria burden. A country facing this level of burden needs malaria funding to do more than procure commodities. It must also strengthen surveillance, disease stratification and subnational management to ensure that bed nets, chemoprevention and vaccines reach the populations where they can have the greatest impact.
The tuberculosis control programme demonstrates what is possible. National notifications increased from approximately 107,000 in 2018 to 459,000 in 2025, against WHO's estimated annual burden of about 510,000 new cases. This progress is largely attributed to improved diagnostics, private-sector engagement and active case-finding. The remaining detection gap and low enrolment for drug-resistant TB treatment are now key priorities.
HIV presents a more urgent transition challenge. Nigeria's response has relied heavily on external funding, with PEPFAR historically supporting much of the treatment programme. The National HIV and AIDS Strategic Plan 2026–2030 and the government's US$346 million co-financing commitment for HIV, TB and malaria in 2026 are important signals. The priority now is ensuring that these commitments are released on time and that services are integrated into primary healthcare and health insurance without disruption.

What would make global funding instruments more effective?

Three things are important. First, investments must align with national health priorities, plans and annual operational frameworks, while strengthening country systems and accountability. Second, funding must predictably support the shared capacities on which all programmes depend, including health information systems, supply chains, the health workforce and primary healthcare. Third, governments and partners need joint transition plans with clear milestones to ensure that domestic financing increases as external support declines, rather than after funding gaps emerge.

Nigeria's domestic financing and response to declining external funding

Domestic financing is critical to sustainability. Nigeria has established important policy foundations. The 2022 National Health Insurance Authority Act made health insurance coverage mandatory, while NHIA reports that enrolment had risen to more than 22 million by mid-2026. This represents progress from the low coverage levels that persisted for nearly two decades before the Act. However, it still covers only about one in 10 Nigerians, leaving most people exposed to out-of-pocket healthcare costs. Enrolment alone does not guarantee financial protection or quality care. The next phase must extend coverage to informal-sector workers and poorer households while tracking not just who is registered but also what people pay and the quality of services they receive.

Effect of the reset on maternal mortality

Reducing maternal mortality remains one of Nigeria's most important health priorities. UN inter-agency estimates put the country's maternal mortality ratio at approximately 993 deaths per 100,000 live births in 2023. However, national and other estimates differ considerably, sometimes by almost half. For instance, the 2024 Nigeria Verbal Autopsy and Social Autopsy Study (NVASA) puts the ratio at 572 deaths per 100,000 live births.
We are working with the government and partners to improve measurement. But the response requires action across the continuum of care, from family planning and antenatal services to skilled delivery, emergency obstetric care and effective referral systems. The 2023–24 Demographic and Health Survey found that only about 15 per cent of married women used a modern contraceptive method, while approximately one in five had an unmet need for family planning.
Helping women avoid unintended pregnancies, space births and prevent unsafe abortions can reduce high-risk pregnancies before obstetric care is even required. This must be complemented by quality antenatal care, skilled birth attendance, emergency obstetric services, access to blood and functioning referral systems. These are health system investments, not isolated programme interventions. They are precisely the kinds of services that health insurance, the Basic Health Care Provision Fund and the SWAp are designed to support.

Requirements for a reset to translate into better outcomes: Where does primary healthcare fit?

Primary healthcare is the foundation of universal health coverage. It is where immunisation, maternal care, malaria services, HIV, tuberculosis and other essential health interventions reach communities. Nigeria has approximately 31,800 primary healthcare facilities, representing about four in five of all health facilities. However, many were non-functional for years. The government's plan to establish at least one fully functional PHC in every political ward, covering approximately 17,600 facilities, with Basic Health Care Provision Fund resources flowing directly to facilities, provides an important framework.
NPHCDA reports that about 8,000 PHCs are functional, with approximately 3,000 upgraded. While encouraging, these are administrative figures. The next step is to verify functionality through joint facility assessments, ensure states access and utilise available funds, and demonstrate improvements in service utilisation and quality. Integrating disease-specific programmes into this platform, rather than running them alongside it, is also essential to managing the transition from external funding without disrupting services.

How serious is the health workforce gap?

Health workers are the backbone of the health system, and shortages remain one of its most binding constraints. Government figures put Nigeria's doctor density at approximately four per 10,000 people nationally, while the 2025 workforce report shows that some northern states have as few as 0.5 doctors per 10,000 people. Emigration has accelerated, and states with some of the highest burdens of maternal deaths, malaria and6 zero-dose children often have the fewest health workers. Nigeria is responding through its National Policy on Health Workforce Migration, expanded training intake and the retraining of tens of thousands of frontline workers. With WHO support, it has also developed a National Health Workforce Registry and country workforce profile. The priority now is retention and equitable deployment. Midwives, nurses and community health workers must be available in the wards and states that need them, supported to remain there, and enabled to provide more services through appropriate task-sharing. Internationally, the WHO Global Code of Practice and managed migration arrangements should encourage destination countries to support the training pipelines on which they depend.

How should progress towards UHC be judged?

Progress should be measured by outcomes for people, not simply by inputs. WHO's UHC service coverage index for Nigeria remains below the regional average, while out-of-pocket payments account for approximately 70–75 per cent of health expenditure. Functioning PHCs, an adequate workforce, reliable medicines and health insurance are the means. The real test is whether essential service coverage improves and fewer households face catastrophic health expenditure. There are, however, reasons to expect progress. Government investments and policy reforms at federal and state levels are increasingly focused on the foundations of UHC: stronger primary healthcare, a fit-for-purpose workforce, reliable access to essential medicines and expanded financial protection through health insurance. If implemented consistently and at scale, these reforms should translate into more people accessing essential services, fewer inequalities between states and population groups, and fewer families pushed into financial hardship by healthcare costs. Ultimately, that is the improvement Nigerians should expect and what the government and its partners must be held accountable for.

How will Nigeria measure the effect of the reset on health outcomes?

Strong data and analytics are essential. Countries need reliable information to track progress, identify gaps, allocate resources and improve outcomes. On maternal mortality, Nigeria has national figures, UN inter-agency estimates and IHME estimates that do not agree. Each uses different data and methodologies, and each is defensible on its own terms. However, policymakers need reliable figures for planning, while the public needs confidence in the data. We are supporting the government to harmonise these efforts through a technical working group on mortality estimation involving WHO, UNFPA, IHME and agencies working on HIV, TB, malaria and injuries. 
This includes working with WHO headquarters to strengthen national and subnational analytical capacity, as well as improving civil registration and vital statistics, including maternal and perinatal death surveillance. The objective is to reduce reliance on periodic surveys and build more reliable national data systems. This is what we mean by an impact focus: using data to monitor progress, identify bottlenecks, solve problems and mobilise the resources and partnerships needed to achieve results. The quarterly performance reviews and Joint Annual Review under the SWAp provide opportunities to put this into practice. Better data will make those assessments more meaningful and help drive corrective action.

Why sub-national capacity matters

National averages can conceal significant inequalities in a country as large and diverse as Nigeria. States and local government areas make critical decisions on polio, malaria chemoprevention and obstetric care. State teams must therefore be able to analyse their own data, reconcile administrative and survey estimates, and use the findings to guide interventions. That capacity will remain long after individual grants expire, and we believe strengthening it is one of the most enduring contributions WHO can make.

Where do digital solutions and artificial intelligence fit in?

Digital transformation in health is not primarily about technology. It is about building stronger, more equitable and people-centred health systems, with technology serving as an enabler. Data and digital transformation is one of the six pillars of WHO's cooperation with Nigeria for this reason. The ambition is not simply to expand digital health but to build connected systems that use technology to deliver measurable improvements. Too often, countries end up with multiple disconnected platforms, each funded by a different partner and unable to communicate with the others. Telemedicine, electronic health records and reporting tools should be integrated into primary healthcare, referral networks and the national health information system, rather than operating alongside them. Artificial intelligence also offers significant opportunities to support health workers, strengthen surveillance, improve decision-making and enhance service delivery. However, AI should complement, not replace, professional judgement. 
Its application must follow WHO guidance on ethics, governance, equity, transparency, accountability, privacy and human rights. Successful deployment depends on strong digital foundations, including quality data, interoperability, cybersecurity, appropriate regulation and a well-trained workforce. Its value should ultimately be measured by improvements in health outcomes, service quality and equity. For Nigeria, three priorities matter. First, governance, standards, interoperability and digital architecture must be treated as national public goods, owned and led by government. Second, digital investments should be judged by their impact on service delivery and health outcomes, not the number of platforms launched. Third, AI should be pursued responsibly, guided by ethics, evidence, safety, national regulation and priorities, with data sovereignty protected and benefits extended to rural communities, women and people with limited digital access. This is also part of the global health architecture debate. Partners, philanthropies and technology companies should invest through Nigeria's national digital health architecture, not around it.

What does the reset mean for WHO?

There have been concerns that WHO country offices have sometimes assumed substantial operational responsibilities, particularly during disease eradication efforts and public health emergencies. In some contexts, this was necessary to sustain critical public health functions and support national priorities. However, such arrangements are not intended to replace sustainable national capacity and leadership in the long term. Our role is evolving in three directions. First, we are increasingly focused on helping countries lead and sustain public health functions by strengthening institutions and systems to independently plan, implement, monitor and improve health programmes. Second, we are shifting from individual projects towards strengthening the health system through norms, guidelines and technical advice that improve multiple programmes. Third, we are moving from reporting activities to demonstrating accountability for outcomes we can reasonably influence. WHO remains fully committed to supporting a nationally led, demand-driven and less fragmented approach.

How do you demonstrate WHO's contribution?

We have to be precise. WHO rarely causes a national result on its own. Governments, communities and many partners contribute to the work. What we can demonstrate is our contribution: a guideline adopted, a surveillance gap closed, a state team equipped to analyse its own data or a policy decision informed by better evidence. We are aligning our country plan around a smaller set of national outcome indicators, each with a clear description of WHO's role and the assumptions behind it. Honest attribution builds more trust than inflated claims.

What should the reform process deliver for Nigeria, and what should Nigeria do?

The reform process should be judged by what changes in countries. It should deliver fewer parallel plans, reports and coordination meetings, and more funding and reporting through a single national plan, budget and accountability framework, such as the SWAp already provides. It should also support predictable investment in shared health system foundations, including data, the workforce, supply chains and primary healthcare, alongside clear and jointly agreed transition timelines.
Nigeria, for its part, must release domestic financing commitments on time, ensure partners channel their funding and reporting through the SWAp, and hold the health system accountable for outcomes rather than activities. If both sides deliver, Nigerians should see fewer children missed by vaccines, fewer deaths from malaria and childbirth, and less money paid out of pocket for healthcare. That is how the reset should ultimately be measured: in lives improved and saved.
I am cautiously optimistic. Nigeria has demonstrated that it can deliver difficult public health interventions at scale, from ending wild poliovirus transmission to vaccinating more than 100 million children through integrated campaigns and significantly expanding TB detection. The capacity exists, although it remains uneven and requires consistent support. WHO's role is to strengthen that capacity, clearly demonstrate its contribution and step back as national institutions take over and sustainably perform these functions. That transition is the real measure of whether our time-limited support has built lasting capacity. If we get it right in Nigeria, the reforms agreed by global health institutions will have greater meaning and deliver more lasting results.

Thursday, November 12, 2026

Nigeria seeks N70bn to implement five-year Oral Health Plan -- Minister


By Precious Dipe 


Nigeria requires about N70 billion over the next five years to implement its National Oral Health Strategic Plan 2026–2030, the Minister of State for Health and Social Welfare, Dr Iziaq Adekunle Salako, has disclosed.

Salako, who made this known in Abuja on November 9, said the plan was designed to expand access to affordable oral healthcare, strengthen preventive services and integrate oral health into primary healthcare delivery across the country.

Speaking at the commemoration of National Noma Day and National Oral Health Day, where he officially launched the strategic plan, the minister said the government was determined to end the neglect of oral health and make it an integral part of Nigeria's Universal Health Coverage drive.

He urged state and local governments to domesticate and implement the plan, while calling on development partners and health professionals to support its execution.

According to him, the five-year roadmap prioritises preventive care, improved access to dental services, workforce development, stronger referral systems and expanded oral healthcare coverage across all 774 local government areas.

Salako said the plan also provides for school oral health programmes, access to fluoride toothpaste, sugar-reduction initiatives and the integration of oral health into nutrition, maternal and child health and non-communicable disease programmes.

He said: "The Plan also seeks to strengthen the health system through the training and equitable distribution of oral health personnel, including Dental Therapists and Dental Surgery Technicians; improved primary healthcare infrastructure and equipment; stronger referral systems; expanded access to care across all 774 Local Government Areas; and enhanced governance, financing, monitoring, and accountability."

The minister identified the country's high burden of untreated oral diseases and inadequate dental workforce as major challenges, noting that more than 80 per cent of Nigerians had never visited a dentist, while two out of every three children lived with untreated dental caries.

He put the dentist-to-population ratio at approximately one dentist to 38,000 people, compared with the World Health Organisation's recommended ratio of one to 7,500.

Salako said most Nigerians still paid out-of-pocket for dental services and often sought treatment only when pain or serious complications developed.

He said the Federal Government was pursuing the integration of oral healthcare into primary healthcare facilities through the Sector-Wide Approach and Basic Health Care Provision Fund to make services more accessible and affordable.

The minister also disclosed that the Federal Executive Council had approved the National Centre for Oral Health Establishment Bill 2026 and forwarded it to the National Assembly for consideration.

On Noma, Salako described the rapidly progressing disease, which destroys tissues of the mouth and face, as an unacceptable public health challenge that should have no place in the 21st century.

He warned that what often begins as a gum infection in a malnourished or immunocompromised child could progress within days to severe facial destruction, disability and death if left untreated.

Nigeria, he said, carries one of the highest burdens of Noma globally, with the North-West and North-East particularly affected.

He noted that survivors also face stigma, social isolation and exclusion, describing the World Health Organisation's recognition of Noma as a neglected tropical disease in 2023 as a significant milestone in efforts to address the condition.

Salako said the government had integrated Noma surveillance into the Integrated Disease Surveillance and Response system and was strengthening the capacity of primary healthcare facilities to identify and refer suspected cases at the earliest stages.

He added that the ministry had trained frontline healthcare workers, traditional healers and traditional birth attendants in 19 states on early identification of Noma and other oral diseases.

Although Noma is more prevalent in northern Nigeria, the training exercises had also resulted in the identification of cases in the South-East, South-South and South-West, underscoring the need for a coordinated national response.

The minister identified good nutrition, exclusive breastfeeding, routine immunisation, proper oral hygiene and prompt treatment of childhood illnesses, including measles and malaria, as essential measures for preventing Noma.

He called for sustained collaboration among government agencies, healthcare professionals, researchers, civil society organisations and development partners to strengthen surveillance, early diagnosis and access to treatment.

Salako specifically commended Médecins Sans Frontières and the Noma Aid Nigeria Initiative for their work at Noma treatment centres in Sokoto and Abuja.

He also urged dental professionals to break down professional barriers and embrace coordinated, people-centred care, while calling on international partners, including WHO, UNICEF and the FDI World Dental Federation, to sustain their support.

The minister said the government's ambition was to ensure that no Nigerian child died or suffered permanent facial disfigurement from a preventable and treatable disease such as Noma.

He called on stakeholders to renew their commitment to eliminating Noma as a public health problem and ensuring that every Nigerian could access quality oral healthcare.

Bean-based chewing gum removes 93% of HPV in saliva, study finds


By Seun Greeners

A new bean-based chewing gum developed by researchers in the United States has shown promising potential to reduce the presence of human papillomavirus (HPV), a major cause of throat cancer, by up to 93 per cent in saliva samples.

The experimental gum, made from lablab beans, also demonstrated the ability to eliminate more than 99 per cent of two cancer-associated bacteria in laboratory tests, raising hopes for a potentially inexpensive approach to reducing exposure to cancer-linked microbes in the mouth.

The findings, published in the journal Scientific Reports, were reported by a research team led by Henry Daniell of the University of Pennsylvania.

HPV is responsible for most cases of oropharyngeal cancer, which affects the back of the throat, including the base of the tongue and tonsils, in the United States. The infection is transmitted through oral contact, and HPV-related throat cancers have become an increasing concern, particularly among men.

The researchers developed the chewing gum using lablab beans (Lablab purpureus), which naturally contain a protein known as FRIL. The protein belongs to a class of plant compounds called lectins, which can bind to viral particles and cause them to clump together.

By trapping viral particles in clusters, FRIL could potentially reduce the amount of detectable HPV in saliva and limit opportunities for its transmission.

To investigate its effectiveness, the researchers processed lablab bean powder into chewing gum tablets and tested extracts from the formulation using donated saliva and mouth-rinse samples from patients with head and neck squamous cell carcinoma.

The results showed that the bean-based gum reduced detectable HPV levels by approximately 93 per cent in saliva samples and 80 per cent in mouth-rinse samples.

The study also tested a second formulation containing protegrin-1, an antimicrobial peptide added to the bean-based preparation to target harmful bacteria.

A single dose of the formulation reduced two bacteria associated with head and neck cancers, Porphyromonas gingivalis and Fusobacterium nucleatum, by more than 99 per cent in the tested samples.

Significantly, the researchers reported that the formulation largely spared beneficial bacteria, including certain protective strains of streptococci, suggesting that it could target harmful microorganisms without indiscriminately disrupting the oral microbial community.

The findings are particularly relevant as researchers continue to investigate the contribution of oral infections and microbial imbalances to the development and progression of head and neck cancers.

While HPV vaccination remains the established preventive intervention against vaccine-targeted HPV infections, the researchers believe the chewing gum could eventually offer an additional approach to reducing viral presence in the mouth.

Daniell said the findings provide a basis for advancing the experimental formulations into clinical trials to determine whether the observed effects can be reproduced when people actually chew the gum.

However, the researchers cautioned against interpreting the results as evidence that the gum can prevent or cure cancer.

The experiments were conducted outside the human body using donated patient samples. The gum itself has not yet been evaluated in clinical trials involving people, meaning its safety, optimal dosage, duration of action and effectiveness in reducing HPV transmission remain unknown.

Whether regularly chewing the formulation can produce sustained reductions in oral HPV levels or translate into fewer cancer cases will also require further investigation.

Nevertheless, the researchers say the plant-based approach offers an interesting possibility for developing an affordable, locally delivered intervention that could complement existing HPV prevention strategies.

For now, the findings represent an early scientific advance rather than a proven preventive treatment, but one that researchers believe is promising enough to warrant testing in humans.

Source: Daniell H. et al. (2026). Ex vivo HNSCC clinical studies using saliva and antiviral or antibacterial chewing gums reveal reduction in carcinogenic microbes. Scientific Reports, 16, 7886.

AMR: Global experts worry over rising antibiotic use, seek urgent action to avert superbug crisis

By Sola Charles  With antibiotic use in livestock projected to rise by nearly 30 per cent by 2040, global health experts have wa...